Turn Therapeutics Inc. Reports Quarterly Results (Quarter Ended June 30, 2026)

What Happened
Turn Therapeutics Inc. announced its financial and operating results for the quarter ended June 30, 2026 via a press release dated August 12, 2026. The company furnished that press release as Exhibit 99.1 to a Form 8‑K (Item 2.02: Results of Operations and Financial Condition) filed on August 12, 2026.

Key Details

• Press release announcing quarterly financial and operating results issued on August 12, 2026.
• Results cover the quarter ended June 30, 2026.
• Press release furnished as Exhibit 99.1 to the Form 8‑K.
• Interactive XBRL cover page data is included (Exhibit 104).

Why It Matters
This 8‑K notifies investors that Turn has publicly disclosed its recent quarterly results and operating updates; investors should review the furnished press release for specific metrics—such as revenue, expenses, cash position, clinical or operational highlights—that could affect valuation and near‑term outlook. The filing ensures the company’s quarterly results are formally available to the market.